- Home
- LPL vs AXSM Comparison
LPL vs AXSM Comparison
Compare LPL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPL
- AXSM
- Stock Information
- Founded
- LPL 1985
- AXSM 2012
- Country
- LPL South Korea
- AXSM United States
- Employees
- LPL N/A
- AXSM N/A
- Industry
- LPL Industrial Machinery/Components
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- LPL Technology
- AXSM Health Care
- Exchange
- LPL Nasdaq
- AXSM Nasdaq
- Market Cap
- LPL 3.2B
- AXSM 4.2B
- IPO Year
- LPL 2004
- AXSM 2015
- Fundamental
- Price
- LPL $3.26
- AXSM $84.60
- Analyst Decision
- LPL Sell
- AXSM Strong Buy
- Analyst Count
- LPL 2
- AXSM 14
- Target Price
- LPL N/A
- AXSM $125.54
- AVG Volume (30 Days)
- LPL 254.2K
- AXSM 893.5K
- Earning Date
- LPL 01-22-2025
- AXSM 02-18-2025
- Dividend Yield
- LPL N/A
- AXSM N/A
- EPS Growth
- LPL N/A
- AXSM N/A
- EPS
- LPL N/A
- AXSM N/A
- Revenue
- LPL $19,931,616,429.00
- AXSM $338,457,000.00
- Revenue This Year
- LPL $25.36
- AXSM $44.77
- Revenue Next Year
- LPL N/A
- AXSM $67.70
- P/E Ratio
- LPL N/A
- AXSM N/A
- Revenue Growth
- LPL 23.27
- AXSM 51.47
- 52 Week Low
- LPL $3.05
- AXSM $64.11
- 52 Week High
- LPL $5.66
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- LPL 50.37
- AXSM 43.66
- Support Level
- LPL $3.05
- AXSM $79.19
- Resistance Level
- LPL $3.30
- AXSM $87.53
- Average True Range (ATR)
- LPL 0.09
- AXSM 4.37
- MACD
- LPL 0.02
- AXSM -0.02
- Stochastic Oscillator
- LPL 55.41
- AXSM 61.27
About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in a number of countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.